Kidney Failure Risk Lowered With SGLT2 Inhibitors

The most commonly applied outcome in trials of kidney function is a broad composite of greater than 50% decline in estimated glomerular filtration rate (eGFR), kidney failure (sustained eGFR <15 mL/min/1.73 m2 or the need for renal replacement…

Continue Reading